Skip to content
Investors dump KRBL after weak Q4 operating show, shares trade 9% down

Investors dump KRBL after weak Q4 operating show, shares trade 9% down

The company#39;s EBITDA margin dipped from 16.5 percent in the previous year to 11.2 percent in the current quarter

Read More

​ The company#39;s EBITDA margin dipped from 16.5 percent in the previous year to 11.2 percent in the current quarter The company#39;s EBITDA margin dipped from 16.5 percent in the previous year to 11.2 percent in the current quarter  Moneycontrol Latest News Read More  

The company#39;s EBITDA margin dipped from 16.5 percent in the previous year to 11.2 percent in the current quarter

EAM Jaishankar to visit South Africa, Namibia from June 1 to 6

EAM Jaishankar to visit South Africa, Namibia from June 1 to 6

“The external affairs minister will visit South Africa from June 1 to 3 to participate in the BRICS foreign ministers meeting being held in Capetown,” the MEA said in a statement.

Read More

​ “The external affairs minister will visit South Africa from June 1 to 3 to participate in the BRICS foreign ministers meeting being held in Capetown,” the MEA said in a statement. “The external affairs minister will visit South Africa from June 1 to 3 to participate in the BRICS foreign ministers meeting being held in Capetown,” the MEA said in a statement.  Moneycontrol Latest News Read More  

“The external affairs minister will visit South Africa from June 1 to 3 to participate in the BRICS foreign ministers meeting being held in Capetown,” the MEA said in a statement.

Torrent Pharma gains 5% after strong Q4 results; Brokerages maintain hold rating

Torrent Pharma gains 5% after strong Q4 results; Brokerages maintain hold rating

Jefferies maintains a “Hold” rating on Torrent Pharma stock with a target price of Rs 1,650 per share and has marginally adjusted their FY24/25 earnings per share (EPS) estimates.

Read More

​ Jefferies maintains a “Hold” rating on Torrent Pharma stock with a target price of Rs 1,650 per share and has marginally adjusted their FY24/25 earnings per share (EPS) estimates. Jefferies maintains a “Hold” rating on Torrent Pharma stock with a target price of Rs 1,650 per share and has marginally adjusted their FY24/25 earnings per share (EPS) estimates.  Moneycontrol Latest News Read More  

Jefferies maintains a “Hold” rating on Torrent Pharma stock with a target price of Rs 1,650 per share and has marginally adjusted their FY24/25 earnings per share (EPS) estimates.

Hold City Union Bank; target of Rs 145: Sharekhan

Hold City Union Bank; target of Rs 145: Sharekhan

Sharekhan recommended Hold rating on City Union Bankn with a target price of Rs 145 in its research report date May 29, 2023.

Read More

​ Sharekhan recommended Hold rating on City Union Bankn with a target price of Rs 145 in its research report date May 29, 2023. Sharekhan recommended Hold rating on City Union Bankn with a target price of Rs 145 in its research report date May 29, 2023.  Moneycontrol Latest News Read More  

Sharekhan recommended Hold rating on City Union Bankn with a target price of Rs 145 in its research report date May 29, 2023.

Hold Oil and Natural Gas Corporation; target of Rs 170: Sharekhan

Hold Oil and Natural Gas Corporation; target of Rs 170: Sharekhan

Sharekhan recommended Hold rating on Oil and Natural Gas Corporation with a target price of Rs 170 in its research report date May 29, 2023.

Read More

​ Sharekhan recommended Hold rating on Oil and Natural Gas Corporation with a target price of Rs 170 in its research report date May 29, 2023. Sharekhan recommended Hold rating on Oil and Natural Gas Corporation with a target price of Rs 170 in its research report date May 29, 2023.  Moneycontrol Latest News Read More  

Sharekhan recommended Hold rating on Oil and Natural Gas Corporation with a target price of Rs 170 in its research report date May 29, 2023.

Hold Dixon Technologies; target of Rs 4050: Sharekhan

Hold Dixon Technologies; target of Rs 4050: Sharekhan

Sharekhan recommended Hold rating on Dixon Technologies with a target price of Rs 4050 in its research report date May 29, 2023.

Read More

​ Sharekhan recommended Hold rating on Dixon Technologies with a target price of Rs 4050 in its research report date May 29, 2023. Sharekhan recommended Hold rating on Dixon Technologies with a target price of Rs 4050 in its research report date May 29, 2023.  Moneycontrol Latest News Read More  

Sharekhan recommended Hold rating on Dixon Technologies with a target price of Rs 4050 in its research report date May 29, 2023.

Hold Greenlam Industries; target of Rs 410: Sharekhan

Hold Greenlam Industries; target of Rs 410: Sharekhan

Sharekhan recommended Hold rating on Greenlam Industries with a target price of Rs 410 in its research report date May 29, 2023.

Read More

​ Sharekhan recommended Hold rating on Greenlam Industries with a target price of Rs 410 in its research report date May 29, 2023. Sharekhan recommended Hold rating on Greenlam Industries with a target price of Rs 410 in its research report date May 29, 2023.  Moneycontrol Latest News Read More  

Sharekhan recommended Hold rating on Greenlam Industries with a target price of Rs 410 in its research report date May 29, 2023.

Modi govt#39;s #39;fire sale#39; of national assets to #39;friends#39; is #39;single biggest anti-national#39; act: Mallikarjun Kharge

Modi govt#39;s #39;fire sale#39; of national assets to #39;friends#39; is #39;single biggest anti-national#39; act: Mallikarjun Kharge

The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.

Read More

​ The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures. The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.  Moneycontrol Latest News Read More  

The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.

Modi govt#39;s #39;fire sale#39; of national assets to #39;friends#39; is #39;single biggest anti-national#39; act: Mallikarjun Kharge

Modi govt#39;s #39;fire sale#39; of national assets to #39;friends#39; is #39;single biggest anti-national#39; act: Mallikarjun Kharge

The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.

Read More

​ The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures. The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.  Moneycontrol Latest News Read More  

The Congress has been running a campaign claiming that the government#39;s nine years have been marked by incompetence and failures.

en_USEnglish
hi_INहिन्दी en_USEnglish